focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpel Priv Eqty Regulatory News (JPEL)

Share Price Information for Jpel Priv Eqty (JPEL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.89
Bid: 0.86
Ask: 0.92
Change: 0.00 (0.00%)
Spread: 0.06 (6.977%)
Open: 0.89
High: 0.89
Low: 0.89
Prev. Close: 0.89
JPEL Live PriceLast checked at -
JPEL Private Equity is an Investment Trust

To effect an orderly realisation of the investments and other assets comprised in the portfolio of the company and will seek to realise such investments and assets in order to maximise returns to US equity shareholders.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Tender Offer

24 Feb 2012 08:37

RNS Number : 0608Y
J.P. Morgan Private Equity Ltd
24 February 2012
 



 

J.P. MORGAN PRIVATE EQUITY LIMITEDCOMPLETES TENDER OFFER TO PURCHASE SHARES

* * *

 

GUERNSEY, 24 FEBRUARY 2012

 

J.P. Morgan Private Equity Limited (the "Company") is pleased to announce that it has accepted the following shares tendered to it at the applicable Net Asset Value per share as at 31 December 2011:

·; 10,706,290 of US$ Equity Shares at a price of USD 1.27 per share1.

o As discussed in the Company's Circular dated 17 November 2011, the total US$ Equity Shares available for tender was 10,706,336 or 3.0% of the 356,877,850 US$ Equity Shares in issue (excluding treasury) at the time that the tender authority was granted.

The 10,706,336 US$ Equity Shares available for tender represents 2.6658772% of the 401,606,496 US$ Equity Shares in issue (excluding treasury) as of the date of the Circular (17 November 2011).

The scaling ratio for US$ Equity shares tendered in excess of the basic entitlement was 0.0033898.

 

·; 153,284 of 2013 Zero Dividend Preference shares at a price of GBP 0.6570 per share.

 

·; 1,514,935 of 2015 Zero Dividend Preference shares at a price of GBP 0.6267 per share.

 

The number of US$ Equity Shares accepted differs from those which were available for tender due to rounding in order to accommodate each shareholder's basic entitlement.

 

The date of the purchase was 21 February 2012. Cheques were despatched / CREST accounts were credited on 24 February 2012 in respect of the shares tendered. All payments were made in the respective base currencies of each share class.

The shares tendered are held as treasury shares. As a result of this tender offer, the Company holds 25,802,704 US$ Equity Shares, 2,259,803 2013 Zero Dividend Preference Shares and 2,344,176 2015 Zero Dividend preference shares in treasury.

 

Immediately following the tender offer the Company's issued share capital will consist of 386,890,704 shares of no par value (excluding treasury shares) each classified as US$ Equity Shares, 63,159,021 shares of no par value (excluding treasury shares) each classified as 2013 Zero Dividend Preference shares, 67,077,371 shares of no par value (excluding treasury shares) each classified as 2015 Zero Dividend Preference Shares, 30,410,753 shares of no par value (excluding treasury shares) each classified as 2017 Zero Dividend Preference Shares.

Therefore the total number of voting rights in the Company is 386,890,704 for the US$ Equity Share class, 63,159,021 for the 2013 Zero Dividend Preference share class and 67,077,371 for the 2015 Zero Dividend Preference share class. These figures may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FSA's Disclosure and Transparency rules.

 

* * *

 

For further information please contact:

 

J.P. Morgan Private Equity Limited

Troy Duncan / Greg Getschow

+44 (0)20 7742 3032 / +1 212 648 1150

Troy.duncan@jpmorgan.com / Gregory.getschow@jpmorgan.com

 

 

Rosemary DeRise / Samantha Ladd

+1 212 648 2980 / +1 212 648 2982

Rosemary.DeRise@jpmorgan.com / Samantha.Ladd@jpmorgan.com

 

 

* * *

 

About J.P. Morgan Private Equity Limited

 

J.P. Morgan Private Equity Limited is a Guernsey registered and incorporated, London Stock Exchange-listed, closed-ended investment company (LSE: JPEL, JPWW, JPEZ, JPZZ, JPSZ) designed primarily to invest in the global private equity market. The investment objective of the Company is to achieve both short and long-term capital appreciation by investing in a well diversified portfolio of private equity fund interests and by capitalising on the inefficiencies of the secondary private equity market.

 

 

END

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TENEAPALADSAEEF
Date   Source Headline
28th Oct 20217:00 amRNSHolding(s) in Company
26th Oct 20214:03 pmRNSHolding(s) in Company
25th Oct 20215:52 pmRNSNet Asset Value - July 2021
30th Sep 20218:27 amRNSAnnual Financial Report - 30 June 2021
12th Aug 20217:00 amRNSCompletion of Ninth Mandatory Redemption
5th Aug 20217:00 amRNSNinth Mandatory Redemption
4th Aug 20213:45 pmRNSNet Asset Value - June 2021
23rd Jul 20213:52 pmRNSLargest Investment Sale & 9th Mandatory Redemption
21st Jul 20213:16 pmRNSNet Asset Value - May 2021
3rd Jun 20213:59 pmRNSNet Asset Value - April 2021
14th May 20213:52 pmRNSNet Asset Value - March 2021
19th Apr 20219:34 amRNSNet Asset Value - February 2021
6th Apr 20217:00 amRNSHolding(s) in Company
1st Apr 20214:21 pmRNSHolding(s) in Company
31st Mar 20215:17 pmRNSNet Asset Value - January 2021
17th Mar 20215:13 pmRNSHalf-year Report - 31 December 2020
24th Feb 20214:35 pmRNSNet Asset Value - December 2020
28th Jan 20215:27 pmRNSHolding(s) in Company
25th Jan 20214:49 pmRNSHolding(s) in Company
15th Jan 20212:01 pmRNSNet Asset Value - November 2020
14th Jan 20213:30 pmRNSHolding(s) in Company
30th Dec 20207:00 amRNSCompletion of 8th Mandatory Redemption
17th Dec 20207:00 amRNSLargest Investment & 8th Mandatory Redemption
11th Dec 20203:01 pmRNSNet Asset Value - October 2020
26th Nov 202010:43 amRNSAGM Results 2020
26th Nov 202010:16 amRNSAGM Results 2020
20th Nov 20207:00 amRNSNet Asset Value - September 2020
18th Nov 20207:00 amRNSStatement re Company Update
13th Nov 20202:49 pmRNSNet Asset Value - August 2020
9th Nov 20204:43 pmRNSNet Asset Value - July 2020
4th Nov 20209:35 amRNS2020 AGM CIRCULAR
8th Oct 20207:00 amRNSAnnual Financial Report - 30 June 2020
16th Sep 202011:55 amRNSNet Asset Value - June 2020
31st Jul 20203:05 pmRNSNet Asset Value - May 2020
24th Jun 20207:00 amRNSNet Asset Value - April 2020
10th Jun 202011:04 amRNSNet Asset Value - March 2020
24th Apr 20207:00 amRNSNet Asset Value - February 2020
14th Apr 20204:47 pmRNSNet Asset Value - January 2020
14th Apr 20203:35 pmRNSNet Asset Value - January 2020
14th Apr 20203:16 pmRNSHolding(s) in Company
1st Apr 20205:35 pmRNSReplacement Completion of 7th Mandatory Redemption
1st Apr 20203:33 pmRNSCompletion of Seventh Mandatory Redemption
25th Mar 20207:00 amRNSSeventh Mandatory Redemption
17th Mar 20203:46 pmRNSHalf-year Report - 31 December 2019
13th Mar 20207:00 amRNSPartial Sale of 2nd Largest Investment
6th Mar 20204:51 pmRNSNet Asset Value(s) - December 2019
10th Jan 20203:21 pmRNSNet Asset Value - November 2019
5th Dec 20194:56 pmRNSNet Asset Value(s) - October 2019
26th Nov 20197:00 amRNSAGM Results 2019
15th Nov 20196:23 pmRNSNet Asset Value(s) - September - Replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.